Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release Breastfeeding
For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release and its risk associated with lactation. We will also discuss the usage of Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release and some common side effects associated with Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release.

What is Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release ?


helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

Purpose: Active ingredients (in each extended-release bi-layer tablet) Purpose Dextromethorphan HBr 60 mg Cough suppressant Guaifenesin 1200 mg Expectorant

Can I use Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release while breastfeeding?

Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release low risk for breastfeeding
Guaifenesin and Dextromethorphan hydrobromide are the two main ingredients of Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release. Based on our individual analysis of Guaifenesin and Dextromethorphan hydrobromide we can safely say that Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release has low risk while breastfeeding. Below we have summarized the usage of Guaifenesin and Dextromethorphan hydrobromide while breastfeeding, we recommend you to go through it for better understanding of your usage.

Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release Breastfeeding Analsys


Guaifenesin while Breastfeeding

Low Risk

CAS Number: 93-14-1

It is used as an expectorant, alone or in association with other products. Proofs on its effectiveness are sparse. In some instances, preparations of Guaifenesin may contain alcohol as excipient with a concentration as high as 5%. At latest update, relevant published data on excretion into breast milk were not found. Until more information on this medication is available, other option known to be safer would be recommended, mostly in the post-natal period or in cases of prematurity. If used while breastfeeding, a moderate use with the lowest dose as possible and avoiding those preparations with alcoholic excipient, should be preferred. Because effectiveness is poor and likelihood of side effects does exist, especially in multi-association, the US Agency for Drug Administration (FDA) is currently doing efforts for discontinuation of this and others at-the-counter products, that are formulated for cough relief (Guaifenesin, Dextromethorphan, Phenylephrine, Pseudoephedrine, Brompheniramine, etc.)

Dextromethorphan hydrobromide while Breastfeeding

Safe

CAS Number: 125-71-3

Cough suppressant related with morphine and codeine which is lacking of analgesic or sedative properties. Commonly prescribed by pediatricians. On latest update relevant data on breastfeeding was not found. Because reported low toxicity and mild side effect it is considered to be safe while breastfeeding. Frequently associated to caffeine and other products that are usually compatible with breastfeeding. Avoid use of multiple drug and alcohol containing medication.


Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release Breastfeeding Analsys - 2


Guaifenesin while Breastfeeding

CAS Number: 93-14-1

Neither the excretion of guaifenesin in milk nor its effect on breastfed infants have been studied. It is unlikely that with usual maternal doses amounts in breastmilk would harm the nursing infant, especially in infants over 2 months of age. It is best to avoid the use of products with a high alcohol content while nursing.

Dextromethorphan hydrobromide while Breastfeeding

CAS Number: 125-71-3

Neither the excretion of dextromethorphan in milk nor its effect on breastfed infants have been studied. It is unlikely that with usual maternal doses amounts in breastmilk would harm the nursing infant, especially in infants over 2 months of age. It is best to avoid the use of products with a high alcohol content while nursing.



What should I do if I am breastfeeding mother and I am already exposed to Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release?

Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release so you should inform him based on your convenience.


My doctor has prescribed me Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release, what should I do?

Though Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release, will my baby need extra monitoring?

Not much monitoring required while using Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release


Who can I talk to if I have questions about usage of Mucinex Dm | Guaifenesin And Dextromethorphan Hydrobromide Tablet, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients